Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and Genomic Characterization of ERBB2-Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort.

JCO global oncology - 1 Oct 2024

Mondaca Sebastián, Walch Henry, Sepúlveda Santiago, Schultz Nikolaus, Muñoz Gonzalo, Yaqubie Amin, Macanas Patricia, Pareja Claudia, Garcia Patricia, Chatila Walid, Nervi Bruno, Li Bob, Harding James J, Viviani Paola, Roa Juan Carlos, Abou-Alfa Ghassan K

Abstract excerpt

PURPOSE: Gallbladder cancer (GBC) is a biliary tract malignancy characterized by its high lethality. Although the incidence of GBC is low in most countries, specific areas such as Chile display a high incidence. Our collaborative study sought to compare clinical and molecular features of GBC cohorts from Chile and the United States with a focus on ERBB2 alterations. METHODS: Patients were accrued at Memorial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Chile

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Erb-b2 Receptor Tyrosine Kinases

Share to Gallbladder Neoplasms

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 39388662
DOI: 10.1200/GO.24.00090
PMCID: PMC11487998

Genes

ERBB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and Genomic Characterization of ERBB2-Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort.PMID 39388662Read ↗

Gallbladder cancer in Chile: what have we learned?Semantic proximity Read ↗

Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention.Semantic proximity Read ↗

Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer.Semantic proximity Read ↗

Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational ApproachSemantic proximity Read ↗

Genomic landscape of gallbladder cancer: insights from whole exome sequencing.Semantic proximity Read ↗

Genomic and molecular landscape of gallbladder cancer elucidating pathogenic mechanisms novel therapeutic targets and clinical implications.Semantic proximity Read ↗

Genomic ERBB2 / ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysisSemantic proximity Read ↗

Geographic and genetic diversity in gallbladder cancer mutation profiles: insights from a worldwide exome analysis.Semantic proximity Read ↗

Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patientsSemantic proximity Read ↗

Precision oncology for gallbladder cancer: insights from genetic alterations and clinical practiceSemantic proximity Read ↗

ERBB2 I655V mutation correlates with efficacy of immunotherapy in gallbladder cancer.Semantic proximity Read ↗

ERBB2 S310F mutation independently activates PI3K/AKT and MAPK pathways through homodimers to contribute gallbladder carcinoma growth.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.